Literature DB >> 6542073

A 5-year prospective case-control study of the influence of early otitis media with effusion on reading achievement.

J Lous, M Fiellau-Nikolajsen.   

Abstract

In a still ongoing prospective longitudinal study, more than 500 children--a total birth-cohort in a Danish municipality--were followed from their 3rd to their 9th year of life by multiple impedance tests in order to investigate a number of factors concerning epidemiology and long-term impacts of otitis media with effusion. This is a report on the influence of otitis media with effusion early in life on reading achievement. The study revealed no difference in school-class level between the 9% of the children (n = 46) who constantly had abnormal tympanometry during a 6-month period at the age of 3, and the other pupils in the municipality. At the Silent Reading Test (OS-400), done on 40 of the 46 case-pupils the results did not differ from (1) the other pupils in the municipality, (2) from other pupils of the same sex in the same classroom, or (3) from individual control-pupils matched by sex, social group and classroom.

Entities:  

Mesh:

Year:  1984        PMID: 6542073     DOI: 10.1016/s0165-5876(84)80022-1

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

Review 1.  Does early detection of otitis media with effusion prevent delayed language development?

Authors:  C C Butler; H MacMillan
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

Review 2.  Identification of children in the first four years of life for early treatment for otitis media with effusion.

Authors:  S A Simpson; C L Thomas; M K van der Linden; H Macmillan; J C van der Wouden; C Butler
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  The Etiology, Pathophysiology, and Management of Otitis Media with Effusion.

Authors:  Christopher C. Butler; R. Gareth Williams
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.